Lista de obras - Reisa Sperling - Dominio Público Uruguay

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease

artículo científico publicado en 2014

A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease

artículo científico publicado en 2016

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

artículo científico publicado en 2014

A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

artículo científico publicado en 2016

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

artículo científico publicado en 2015

Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers

scientific article published on 12 August 2019

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup

artículo científico publicado en 2011

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

artículo científico publicado en 2012

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

artículo científico publicado en 2015

Amyloid-β associated cortical thinning in clinically normal elderly

artículo científico publicado en 2011

Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau

artículo científico publicado en 2012

Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent?

article

Assessment of cognition in early dementia

artículo científico publicado en 2011

Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons

artículo científico publicado en 2017

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans

artículo científico publicado en 2012

Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease

artículo científico publicado en 2012

Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab

artículo científico publicado en 2018

Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria

artículo científico

Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study

Building a roadmap for developing combination therapies for Alzheimer's disease

artículo científico publicado en 2015

CAP--advancing the evaluation of preclinical Alzheimer disease treatments

artículo científico publicado en 2015

Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease

artículo científico publicado en 2015

Challenges, solutions, and recommendations for Alzheimer's disease combination therapy

artículo científico publicado en 2016

Charting a path toward combination therapy for Alzheimer's disease

artículo científico

Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies

artículo científico publicado en 2018

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

artículo científico publicado en 2012

Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials

artículo científico publicado en 2016

Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group

artículo científico publicado en 2016

Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study

article

Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease

artículo científico publicado en 2017

Defeating Alzheimer's disease and other dementias: a priority for European science and society

artículo científico publicado en 2016

Dementia is not synonymous with Alzheimer's disease

artículo científico publicado en 2019

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force

artículo científico publicado en 2013

Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.

artículo científico publicado en 2011

Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network

artículo científico publicado en 2012

Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants

artículo científico publicado en 2015

Early risk assessment for Alzheimer's disease

artículo científico publicado en 2009

Epicenters of dynamic connectivity in the adaptation of the ventral visual system

artículo científico publicado en 2016

Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly

artículo científico publicado en 2016

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

artículo científico publicado en 2016

Functional MRI detection of pharmacologically induced memory impairment

artículo científico publicado en 2001

Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease

artículo científico publicado en 2007

Functional connectivity in autosomal dominant and late-onset Alzheimer disease

artículo científico publicado en 2014

Genetic variants and functional pathways associated with resilience to Alzheimer's disease

scientific article published on 01 August 2020

Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex

artículo científico publicado en 2017

Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults

artículo científico publicado en 2011

Imaging markers for Alzheimer disease: which vs how

artículo científico publicado en 2013

Impaired default network functional connectivity in autosomal dominant Alzheimer disease

artículo científico publicado en 2013

Implementation of subjective cognitive decline criteria in research studies

artículo científico publicado en 2016

In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain

artículo científico publicado en 2016

In vivo characterization of the early states of the amyloid-beta network

artículo científico publicado en 2013

Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease

artículo científico publicado en 2003

Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA?

artículo científico publicado en 2013

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

artículo científico publicado en 2011

Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

artículo científico publicado en 2019

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease

artículo científico publicado en 2014

Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease

artículo científico publicado en 2018

Mapping the road forward in Alzheimer's disease

artículo científico publicado en 2011

Mild to moderate Alzheimer dementia with insufficient neuropathological changes

artículo científico publicado en 2014

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

artículo científico publicado en 2018

On the path to 2025: understanding the Alzheimer's disease continuum

artículo científico publicado en 2017

Partial volume correction in quantitative amyloid imaging

artículo científico publicado en 2014

Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals

artículo científico publicado en 2017

Potential of functional MRI as a biomarker in early Alzheimer's disease

artículo científico publicado en 2011

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

artículo científico publicado en 2016

Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.

artículo científico publicado en 2013

Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls

artículo científico publicado en 2015

Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.

artículo científico publicado en 2018

Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.

artículo científico publicado en 2017

Pro: Can biomarkers be gold standards in Alzheimer's disease?

artículo científico publicado en 2010

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review

artículo científico publicado en 2013

Putting names to faces: successful encoding of associative memories activates the anterior hippocampal formation

artículo científico publicado en 2003

Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group

artículo científico publicado en 2016

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

artículo científico publicado en 2013

Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease

artículo científico publicado en 2018

Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non‐demented elderly adults ⬇️

artículo científico publicado el 21 de enero de 2011

Reply: LATE to the PART-y

artículo científico publicado en 2019

Research priorities to reduce the global burden of dementia by 2025.

artículo científico publicado en 2016

Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report

artículo científico publicado en 2019

Selective disruption of the cerebral neocortex in Alzheimer's disease

artículo científico publicado en 2010

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease

scientific article published on 06 June 2020

Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's disease

artículo científico publicado en 2011

Subjective Cognitive Decline Is Associated With Altered Default Mode Network Connectivity in Individuals With a Family History of Alzheimer's Disease

scholarly article by Sander C.J. Verfaillie et al published May 2018 in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies

artículo científico publicado en 2015

Subjective cognitive concerns, episodic memory, and the APOE ε4 allele

artículo científico publicado en 2014

Suspected non-Alzheimer disease pathophysiology--concept and controversy

artículo científico publicado en 2016

Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis

artículo científico publicado en 2014

Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity

artículo científico publicado en 2019

Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases

artículo científico publicado en 2016

Tau positron emission tomographic imaging in aging and early Alzheimer disease

artículo científico publicado en 2015

Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary

artículo científico publicado en 2016

The ADNI Publication Policy: commensurate recognition of critical contributors who are not authors

artículo científico publicado en 2011

The Effectiveness of Small-group Community-based Information Sessions on Clinical Trial Recruitment for Secondary Prevention of Alzheimer's Disease

artículo científico publicado en 2016

The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations

artículo científico publicado en 2014

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals

artículo científico publicado en 2008

The dynamics of cortical and hippocampal atrophy in Alzheimer disease

artículo científico publicado en 2011

The evolution of preclinical Alzheimer's disease: implications for prevention trials

artículo científico publicado en 2014

The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study

artículo científico publicado en 2013

The preclinical Alzheimer cognitive composite: measuring amyloid-related decline

artículo científico publicado en 2014

The role of neuroimaging in elucidating delirium pathophysiology

artículo científico publicado en 2006

To sleep, perchance to delay dementia

artículo científico publicado en 2012

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

artículo científico publicado en 2011

Two macroscopic and microscopic brain imaging studies of human hippocampus in early Alzheimer's disease and schizophrenia research

artículo científico publicado en 2004

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

artículo científico publicado en 2014

Understanding Conflicting Neuropathological Findings in Patients Clinically Diagnosed as Having Alzheimer Dementia.

artículo científico publicado en 2015

White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease.

artículo científico publicado en 2018

White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network

artículo científico publicado en 2016

Lista de obras de Reisa Sperling

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease

A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects

Amyloid imaging of dutch-type hereditary cerebral amyloid angiopathy carriers

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

Amyloid-β 11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Amyloid-β associated cortical thinning in clinically normal elderly

Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau

Are early atrophy patterns in autosomal dominant familial Alzheimer's disease gene-dependent?

Assessment of cognition in early dementia

Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons

Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans

Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease

Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab

Biomarkers of Alzheimer disease: current and future applications to diagnostic criteria

Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study

Building a roadmap for developing combination therapies for Alzheimer's disease

CAP--advancing the evaluation of preclinical Alzheimer disease treatments

Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease

Challenges, solutions, and recommendations for Alzheimer's disease combination therapy

Charting a path toward combination therapy for Alzheimer's disease

Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials

Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group

Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study

Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease

Defeating Alzheimer's disease and other dementias: a priority for European science and society

Dementia is not synonymous with Alzheimer's disease

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force

Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010.

Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network

Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants

Early risk assessment for Alzheimer's disease

Epicenters of dynamic connectivity in the adaptation of the ventral visual system

Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly

Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit

Functional MRI detection of pharmacologically induced memory impairment

Functional MRI studies of associative encoding in normal aging, mild cognitive impairment, and Alzheimer's disease

Functional connectivity in autosomal dominant and late-onset Alzheimer disease

Genetic variants and functional pathways associated with resilience to Alzheimer's disease

Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex

Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults

Imaging markers for Alzheimer disease: which vs how

Impaired default network functional connectivity in autosomal dominant Alzheimer disease

Implementation of subjective cognitive decline criteria in research studies

In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain

In vivo characterization of the early states of the amyloid-beta network

Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease

Inflammatory cerebral amyloid angiopathy and amyloid-modifying therapies: variations on the same ARIA?

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease

Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease

Mapping the road forward in Alzheimer's disease

Mild to moderate Alzheimer dementia with insufficient neuropathological changes

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

On the path to 2025: understanding the Alzheimer's disease continuum

Partial volume correction in quantitative amyloid imaging

Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals

Potential of functional MRI as a biomarker in early Alzheimer's disease

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.

Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls

Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing.

Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.

Pro: Can biomarkers be gold standards in Alzheimer's disease?

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer's disease: a selective review

Putting names to faces: successful encoding of associative memories activates the anterior hippocampal formation

Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group

Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease

Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease

Reliability of functional magnetic resonance imaging associative encoding memory paradigms in non‐demented elderly adults ⬇️

Reply: LATE to the PART-y

Research priorities to reduce the global burden of dementia by 2025.